Publications by authors named "Kelly L Barton"

6Publications

A Novel Mouse Model of Diffuse Intrinsic Pontine Glioma Initiated in Pax3-Expressing Cells.

Neoplasia 2016 Jan;18(1):60-70

Division of Pediatric Hematology-Oncology, Duke University Medical Center, Durham, NC; Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, NC; Department of Pathology, Duke University Medical Center, Durham, NC. Electronic address:

View Article and Find Full Text PDF
January 2016

A high-throughput in vitro drug screen in a genetically engineered mouse model of diffuse intrinsic pontine glioma identifies BMS-754807 as a promising therapeutic agent.

PLoS One 2015 6;10(3):e0118926. Epub 2015 Mar 6.

Department of Pediatrics, Duke University Medical Center, Durham, NC, United States of America; Department of Pathology, Duke University Medical Center, Durham, NC, United States of America; Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, NC, United States of America.

View Article and Find Full Text PDF
February 2016

Pax3 expression enhances PDGF-B-induced brainstem gliomagenesis and characterizes a subset of brainstem glioma.

Acta Neuropathol Commun 2014 Oct 21;2:134. Epub 2014 Oct 21.

Division of Pediatric Hematology-Oncology, Duke University Medical Center, Durham, NC, USA.

View Article and Find Full Text PDF
October 2014

PD-0332991, a CDK4/6 inhibitor, significantly prolongs survival in a genetically engineered mouse model of brainstem glioma.

PLoS One 2013 2;8(10):e77639. Epub 2013 Oct 2.

Department of Pediatrics, Duke University, Durham, North Carolina, United States of America ; Preston Robert Tisch Brain Tumor Center, Duke University, Durham, North Carolina, United States of America.

View Article and Find Full Text PDF
April 2014

Targeting sonic hedgehog-associated medulloblastoma through inhibition of Aurora and Polo-like kinases.

Cancer Res 2013 Oct 25;73(20):6310-22. Epub 2013 Sep 25.

Authors' Affiliations: Tumor Initiation and Maintenance Program, National Cancer Institute (NCI)-Designated Cancer Center, Sanford-Burnham Medical Research Institute; Sanford Consortium for Regenerative Medicine; Departments of Pediatrics, Neurosciences, and Neurosurgery, University of California San Diego, La Jolla; Rady Children's Hospital, San Diego, California; Departments of Pharmacology and Cancer Biology, Medicine, Division of Pulmonary, Allergy, and Critical Care, Pediatrics, Division of Pediatric Hematology/Oncology, and Surgery, Duke University Medical Center, Durham, North Carolina; German Cancer Research Center (DKFZ), Heidelberg, Germany; and Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada.

View Article and Find Full Text PDF
October 2013